Free Trial

MoonLake Immunotherapeutics (MLTX) Institutional Ownership

MoonLake Immunotherapeutics logo
$18.39 -0.02 (-0.11%)
Closing price 04:00 PM Eastern
Extended Trading
$18.40 +0.01 (+0.05%)
As of 04:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for MoonLake Immunotherapeutics (NASDAQ:MLTX)

Current
Institutional Ownership
Percentage
93.85%
Number of
Institutional Buyers
(last 12 months)
91
Total
Institutional Inflows
(last 12 months)
$300.47M
Number of
Institutional Sellers
(last 12 months)
50
Total
Institutional Outflows
(last 12 months)
$139.71M
Get MLTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling MoonLake Immunotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

MLTX Institutional Buying and Selling by Quarter

MoonLake Immunotherapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/7/2026 Dimensional Fund Advisors LP26,307$490K0.0%-85.7%0.037%
5/1/2026 Candriam S.C.A.818,126$15.25M0.1%+509.0%1.141%
4/27/2026 Y Intercept Hong Kong Ltd127,087$2.37M0.0%+32.4%0.177%
4/16/2026 SG Americas Securities LLC9,350$174K0.0%-57.3%0.013%
3/20/2026 Hsbc Holdings PLC11,095$147K0.0%N/A0.015%
3/3/2026 Caitong International Asset Management Co. Ltd6,950$92K0.0%-91.8%0.011%
2/23/2026Virtu Financial LLC12,582$166K0.0%N/A0.020%
2/19/2026T. Rowe Price Investment Management Inc.3,557$47K0.0%N/A0.006%
2/18/2026Vident Advisory LLC15,444$204K0.0%N/A0.024%
2/18/2026XTX Topco Ltd22,973$303K0.0%-28.8%0.036%
2/18/2026Virtus Investment Advisers LLC17,987$237K0.1%+595.8%0.028%
2/18/2026Susquehanna Portfolio Strategies LLC253,974$3.35M0.1%N/A0.395%
2/18/2026Quadrature Capital Ltd50,217$662K0.0%N/A0.078%
2/18/2026Millennium Management LLC802,722$10.58M0.0%+709.4%1.250%
2/18/2026Janus Henderson Group PLC2,095,988$27.66M0.0%+18,782.8%3.263%
2/18/2026Cinctive Capital Management LP37,194$490K0.0%N/A0.058%
2/18/2026Cormorant Asset Management LP4,355,433$57.41M2.7%+118.4%6.781%
2/18/2026Balyasny Asset Management L.P.1,571,071$20.71M0.0%-9.1%2.446%
2/17/2026Logos Global Management LP1,750,000$23.07M1.4%N/A2.725%
2/17/2026Schonfeld Strategic Advisors LLC322,261$4.25M0.0%-66.6%0.502%
2/17/2026AQR Capital Management LLC32,886$433K0.0%N/A0.051%
2/17/2026Jain Global LLC70,611$931K0.0%N/A0.110%
2/17/2026Trexquant Investment LP184,319$2.43M0.0%N/A0.287%
2/17/2026Jump Financial LLC425,559$5.61M0.1%N/A0.663%
2/17/2026Price T Rowe Associates Inc. MD959,553$12.65M0.0%+16.6%1.494%
2/17/2026T. Rowe Price Investment Management Inc.3,557$47K0.0%N/A0.006%
2/17/2026Rock Springs Capital Management LP61,700$813K0.0%+118.8%0.096%
2/17/2026Weiss Asset Management LP332,961$4.39M0.1%N/A0.518%
2/17/2026California State Teachers Retirement System29,296$386K0.0%+54.4%0.046%
2/17/2026 Russell Investments Group Ltd.3,426$45K0.0%+45.4%0.005%
2/17/2026Granahan Investment Management LLC198,307$2.61M0.1%N/A0.309%
2/17/2026ExodusPoint Capital Management LP212,996$2.81M0.0%+610.0%0.332%
2/17/2026Graham Capital Management L.P.24,292$320K0.0%N/A0.038%
2/17/2026Rice Hall James & Associates LLC127,465$1.68M0.1%-5.5%0.198%
2/16/2026Squarepoint Ops LLC121,640$1.60M0.0%+179.1%0.189%
2/16/2026Mariner LLC20,159$266K0.0%N/A0.031%
2/16/2026Entropy Technologies LP30,300$399K0.0%N/A0.047%
2/16/2026Barclays PLC50,251$662K0.0%+526.9%0.078%
2/13/2026 Kestra Advisory Services LLC2,000$26K0.0%N/A0.003%
2/13/2026The Manufacturers Life Insurance Company 85,570$1.13M0.0%+31.1%0.133%
You're not getting into the SpaceX IPO. Do this instead. (Ad)

The SpaceX IPO is expected to price at $1.75 trillion - and retail investors won't get an allocation. Banks and insiders have already locked it up. But there is one small, publicly traded company that builds the critical infrastructure SpaceX cannot operate without. Dylan Jovine is releasing the ticker name today at no cost.tc pixel

Get the SpaceX backdoor ticker symbol before the market opens
2/13/2026Kalehua Capital Management LLC175,734$2.32M2.1%N/A0.274%
2/13/2026Vivo Capital LLC1,000,000$13.18M0.9%N/A1.557%
2/13/2026State Street Corp50,973$672K0.0%-3.6%0.079%
2/13/2026 Caitong International Asset Management Co. Ltd7,095$94K0.3%-91.6%0.011%
2/13/2026 Wells Fargo & Company MN10,000$132K0.0%+92.0%0.016%
2/13/2026Rhenman & Partners Asset Management AB364,000$4.80M0.4%+75.8%0.567%
2/12/2026HRT Financial LP635,901$8.38M0.0%+343.8%0.990%
2/12/2026 Brooklyn Investment Group14,920$204K0.0%N/A0.023%
2/12/2026Renaissance Technologies LLC134,472$1.77M0.0%N/A0.209%
2/12/2026 Dimensional Fund Advisors LP183,552$2.42M0.0%+1,568.4%0.286%
2/12/2026Ensign Peak Advisors Inc4,489$59K0.0%-19.0%0.007%
2/12/2026Campbell & CO Investment Adviser LLC13,448$177K0.0%N/A0.021%
2/12/2026 Alps Advisors Inc.58,169$767K0.0%+89.1%0.091%
2/12/2026 Swiss National Bank61,500$811K0.0%+43.0%0.096%
2/12/2026 Nuveen LLC637,434$8.40M0.0%+0.3%0.992%
2/11/2026Axiom Investors LLC DE25,998$343K0.0%+3.2%0.040%
2/11/2026 Fox Run Management L.L.C.71,962$948K0.1%+531.2%0.112%
2/11/2026JPMorgan Chase & Co.837,739$11.04M0.0%+381.0%1.304%
2/10/2026 TD Asset Management Inc126,744$1.67M0.0%+18.9%0.197%
2/10/2026Goldman Sachs Group Inc.270,665$3.57M0.0%-25.4%0.421%
2/9/2026Geode Capital Management LLC72,606$956K0.0%+16.4%0.113%
2/9/2026Jefferies Financial Group Inc.500,000$6.59M0.0%+1,900.0%0.778%
2/6/2026Eagle Health Investments LP187,600$2.47M0.5%N/A0.292%
2/6/2026 GSA Capital Partners LLP89,236$1.18M0.1%N/A0.139%
1/29/2026 UBS Group AG239,020$3.15M0.0%+183.4%0.372%
1/27/2026Zurcher Kantonalbank Zurich Cantonalbank13,592$179K0.0%+129.6%0.021%
1/9/2026 Congress Asset Management Co.71,096$937K0.0%-3.1%0.111%
1/9/2026 SG Americas Securities LLC21,888$288K0.0%+24.9%0.034%
1/1/2026JPMorgan Chase & Co.174,161$1.25M0.0%+342.1%0.271%
12/15/2025 FNY Investment Advisers LLC4,000$28K0.0%N/A0.006%
11/19/2025 Caitong International Asset Management Co. Ltd84,553$606K0.4%+22,387.5%0.132%
11/17/2025Woodline Partners LP60,854$436K0.0%-80.4%0.095%
11/17/2025Voleon Capital Management LP40,273$289K0.0%N/A0.063%
11/17/2025Verition Fund Management LLC272,768$1.96M0.0%+1,059.4%0.425%
11/17/2025Quarry LP9,001$65K0.0%+400.1%0.014%
11/17/2025Prelude Capital Management LLC44,779$321K0.0%N/A0.070%
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.11,954$86K0.0%-24.1%0.019%
11/17/2025HighVista Strategies LLC19,059$137K0.0%-9.0%0.030%
11/17/2025Boxer Capital Management LLC250,000$1.79M0.6%N/A0.389%
11/17/2025Bank of America Corp DE4,532$32K0.0%+64.7%0.007%
11/17/2025Aquatic Capital Management LLC7,890$57K0.0%-54.5%0.012%
11/14/2025Schonfeld Strategic Advisors LLC965,405$6.92M0.0%N/A1.503%
11/14/2025Bellevue Group AG35,052$251K0.0%+1,068.4%0.055%
11/14/2025Zurcher Kantonalbank Zurich Cantonalbank 5,919$42K0.0%+115.0%0.009%
11/14/2025Two Sigma Investments LP454,268$3.26M0.0%N/A0.707%
11/14/2025Avoro Capital Advisors LLC2,000,000$14.34M0.2%-51.8%3.114%
11/13/2025 UBS Group AG84,347$605K0.0%+5.0%0.131%
11/13/2025 BNP Paribas Financial Markets7,296$52K0.0%+18.9%0.011%
11/13/2025Franklin Resources Inc.33,577$241K0.0%N/A0.052%
11/13/2025Schroder Investment Management Group195,490$1.40M0.0%+908.2%0.304%
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad)

Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel

Get the name and ticker of Louis Navellier's #1 AI stock free
11/13/2025Jefferies Financial Group Inc.25,000$179K0.0%+381.8%0.039%
11/13/2025Rhenman & Partners Asset Management AB207,000$1.48M0.2%+360.0%0.322%
11/12/2025 Dimensional Fund Advisors LP11,002$79K0.0%-79.1%0.017%
11/12/2025Victory Capital Management Inc.18,790$135K0.0%-86.4%0.029%
11/12/2025 Fox Run Management L.L.C.11,400$82K0.0%N/A0.018%
11/10/2025 TD Asset Management Inc106,610$764K0.0%-42.7%0.166%
11/7/2025JPMorgan Chase & Co.174,161$1.25M0.0%+342.1%0.271%
11/6/2025 Candriam S.C.A.133,642$958K0.0%-7.7%0.208%
11/5/2025 Alps Advisors Inc.30,756$221K0.0%-10.3%0.048%
11/4/2025 Principal Financial Group Inc.70,943$509K0.0%N/A0.110%


MLTX Institutional Ownership - Frequently Asked Questions

During the previous two years, 154 institutional investors and hedge funds held shares of MoonLake Immunotherapeutics. The most heavily invested institutionals were BVF Inc. IL ($1.07B), FMR LLC ($343.39M), Holocene Advisors LP ($79.92M), Polar Capital Holdings Plc ($59.57M), Westfield Capital Management Co. LP ($59.44M), Federated Hermes Inc. ($58.93M), and Cormorant Asset Management LP ($57.41M).Learn more on MoonLake Immunotherapeutics' institutional investors.

93.85% of MoonLake Immunotherapeutics' stock is owned by institutional investors. Learn more on MLTX's institutional investor holdings.

Of the 136 institutional investors that purchased MoonLake Immunotherapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: FMR LLC ($2.70M), Logos Global Management LP ($2.50M), Cormorant Asset Management LP ($2.36M), Janus Henderson Group PLC ($2.08M), Millennium Management LLC ($1.22M), Vivo Capital LLC ($1M), and JPMorgan Chase & Co. ($971.66K).

Institutional investors have bought a total of 18,803,176 shares in the last 24 months. This purchase volume represents approximately $300.47M in transactions.

Of the 47 institutional investors that sold MoonLake Immunotherapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Avoro Capital Advisors LLC ($2.15M), Paradigm Biocapital Advisors LP ($1.14M), Schonfeld Strategic Advisors LLC ($643.14K), Goldman Sachs Group Inc. ($474.26K), Woodline Partners LP ($249.75K), Dimensional Fund Advisors LP ($198.96K), and Westfield Capital Management Co. LP ($175.39K).

Institutional investors have sold a total of 6,427,236 shares in the last 24 months. This volume of shares sold represents approximately $139.71M in transactions.



This page (NASDAQ:MLTX) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners